In the last decade (2010–2020), more than half of European countries have improved their health policies within the primary care for type 2 diabetes mellitus. Community pharmacies have been and could continue to be essential actors in this evolution of fighting the disease by providing a set of pharmacotherapeutic follow-up services for the person with diabetes. These services, designated by the Pharmaceutical Group of the European Union as “diabetes management” and “glucose measurement”, have aimed to optimize adherence to therapy and improve health outcomes. However, to follow the European guidelines of Good Pharmacy Practice, providing these services implies having a normative framework or a legal basis. Thus, this study sought to analyze the normative and regulatory framework on which community pharmacies in 28 European countries were based on providing this health care over the last decade.

Keywords:
Type 2 diabetes mellitus, Community pharmacy services, Health policies, Regulatory policies

Na última década (2010–2020), mais da metade dos países europeus melhoraram as suas políticas de saúde no âmbito dos cuidados de saúde primários para a diabetes mellitus tipo 2. As farmácias comunitárias foram e poderão continuar a ser importantes intervenientes nesta evolução de combate à doença, através da disponibilização de um conjunto de serviços de acompanhamento farmacoterapêutico para a pessoa com diabetes. Serviços esses, designados, pelo Grupo Farmacêutico da União Europeia por “diabetes management” e “glucose measurement”, visam otimizar a adesão à terapêutica e melhorar os resultados de saúde. No entanto, seguir as directrizes euro-peias das Boas Práticas de Farmácia, para a realização destes serviços, implica dispor de um enquadramento normativo ou uma base jurídica. Assim, este estudo procurou analisar o arcabouço normativo e regulamentar, em que as farmácias comunitárias de 28 países europeus assentaram, para prestar estes cuidados de saúde, durante a última década.

Palavras ChaveDiabetes mellitus tipo 2, Serviços de farmácia comunitária, Políticas de saúde, Regulamentação

Keywords:
Type 2 diabetes mellitus, Community pharmacy services, Health policies, Regulatory policies
This content is only available via PDF.
© 2021 The Author(s). Published by S. Karger AG, Basel on behalf of NOVA National School of Public Health
2021
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .
Attribution-NonCommercial